Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
V-Spot Vaginal Probiotic Pessary is a live biotherapeutic product developed by Amelia Bio, currently in Phase 2 clinical development. It is designed as a vaginally-inserted pessary that delivers specific beneficial *Lactobacillus* strains directly to the vaginal environment. The mechanism of action focuses on restoring and maintaining a healthy vaginal microbiota by bypassing the gastrointestinal tract, which is intended to improve outcomes in women with unexplained infertility. The product is being developed in collaboration with institutions such as The University of Western Australia and UNSW Sydney.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on V-Spot Vaginal Probiotic Pessary.